• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchDermata Therapeutics
    Picture of Dermata Therapeutics logo

    DRMA — Dermata Therapeutics News Story

    $0.780.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $3.87m
    • Enterprise Value
      -$0.54m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • DRMA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    DRMA Dividends
    All News

    NASDAQ RESUMED AT 10:31 AM

    Picture of Dermata Therapeutics logoDermata Therapeutics
    15/10/2026 15:31
    NASDAQ RESUMED  AT 10:31 AM

    Recent news on Dermata Therapeutics

    See all news
    • NASDAQ RESUMED AT 10:31 AM

      15/10/2026 15:31
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:26 AM

      15/10/2026 15:26
    • Brief: Dermata Therapeutics - To Launch First Commercial Product Tome Foundational Treatment On August 25, 2026

      11/08/2026 22:10
    • Dermata Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

      11/08/2026 22:02
    • Dermata Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview

      07/08/2026 21:25

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.